General MedicationsINTRAVENOUSStandard

ZOLEDRONIC ACID

Standard Dose

EQ 5MG BASE/100ML

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview ZOLEDRONIC ACID is listed in Drugs@FDA under application 213371 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ZOLEDRONIC ACID Form and strength INJECTABLE;INTRAVENOUS - EQ 5MG BASE/100ML Sponsor MEITHEAL Submission history Latest submission status date: 2023-06-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZOLEDRONIC ACID is listed in Drugs@FDA under application 213371 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ZOLEDRONIC ACID Form and strength INJECTABLE;INTRAVENOUS - EQ 5MG BASE/100ML Sponsor MEITHEAL Submission history Latest submission status date: 2023-06-05 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.